Your CMS GUIDE Partner for Specialized Dementia Support

Learn more

Brook Croke

February 9, 2024
Why Genetic Testing is Valuable for Individuals with Neurodegenerative Disorders
Clarifying the odd that a diagnosis is genetic in nature

.avif)
February 9, 2024
First Gene-Specific ALS Treatment Approved on DNA Day
Biogen’s QALSODY receives accelerated approval by the FDA for SOD1-ALS

February 9, 2024
Baking with Barb
My name is Brook and I am a genetic counselor at Synapticure. I’d like to share my personal experience with ALS and how it motivates me in my work at Synapticure.